The world of cancer research and treatment is evolving, and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is leading the charge with a bold initiative. With a prestigious $3 million grant from the National Cancer Institute (NCI), UMGCCC is taking a proactive approach to training the next generation of oncology researchers, with a focus on health equity and community-informed care.
A Vision for the Future of Oncology
The Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program is an ambitious endeavor, aiming to support early-career faculty and postdoctoral fellows who are passionate about improving cancer outcomes for patients from diverse backgrounds. This program is a testament to UMGCCC's commitment to addressing cancer disparities and ensuring that all patients, regardless of their background, have access to the best possible care.
What makes this initiative particularly fascinating is its focus on community engagement. UMGCCC has built deep trust with the Baltimore community, and this grant will allow them to further invest in research programs that engage learners at all levels, from middle school students to postdoctoral trainees. By connecting early-career researchers with community members, UMGCCC is fostering a culture of collaboration and innovation that will undoubtedly drive meaningful change.
A Team of Experts
At the helm of this initiative is Dr. Taofeek K. Owonikoko, Executive Director of UMGCCC and a distinguished professor in oncology. He is joined by two Co-Principal Investigators, Dr. Stuart Martin, UMGCCC Deputy Director, and Dr. Rebecca G. Nowak, Associate Professor of Epidemiology & Public Health. Together, this team brings a wealth of expertise and a shared vision for the future of oncology.
Dr. Martin, who also serves as the Chair of Pharmacology & Physiology at the UM School of Medicine, emphasizes the importance of investing in early-career researchers. He believes that this grant will have a tangible impact on patients in the near future, as these researchers bring fresh perspectives and a commitment to community oncology.
Dr. Nowak, an epidemiologist, is excited about the opportunity to make breakthroughs in cancer prevention and tracking. With the support of the NCI award, she aims to answer critical questions about the disease and its impact on communities, contributing to a deeper understanding of cancer disparities.
A National Recognition
UMGCCC's efforts have not gone unnoticed. The center was the only Cancer Center in the country to receive this grant from the NCI in 2025, a testament to its excellence in community-informed research and treatment. This recognition highlights UMGCCC's unique relationship with the community and its sustained investment in research programs that engage and empower learners.
A Call to Action
The $3 million award, distributed over five years, is a significant investment in the future of oncology. Interested applicants affiliated with the University of Maryland Baltimore (UMB) are encouraged to apply for the ARCH K12 Program by April 8, 2026. Accepted scholars will benefit from comprehensive support and mentorship, setting them on a path to make a real difference in the fight against cancer.
A Broader Perspective
This initiative is not just about training researchers; it's about transforming the way we approach cancer care. By focusing on health equity and community engagement, UMGCCC is challenging the status quo and paving the way for a more inclusive and effective healthcare system. This grant is a step towards a future where cancer disparities are addressed, and every patient has access to the best possible treatment and support.
In my opinion, initiatives like these are a testament to the power of collaboration and a commitment to social justice. By investing in early-career researchers and engaging with communities, UMGCCC is not only advancing oncology but also shaping a brighter and healthier future for us all.
